Surgical Director of The Neuroendocrine Institute at Rocky Mountain Cancer Centers
Rocky Mountain Cancer Centers
Eric Liu, MD, FACS, is a board-certified general surgeon with advanced subspecialty expertise in neuroendocrine cancers. He is the Surgical Director of The Neuroendocrine Institute at Rocky Mountain Cancer Centers and treats patients with neuroendocrine and carcinoid tumors. His practice encompasses all types of neuroendocrine tumors, including lung, bowel, pancreas, stomach, liver, and adrenal. Dr. Liu routinely gives lectures on neuroendocrine around the country and internationally. The Neuroendocrine Institute established a new theranostics center that offers Peptide Receptor Radionuclide Therapy (PRRT, Lutathera®), Gallium and Copper DOTATATE PET/CT imaging, and nuclear clinical trials. He also works closely with collaborators around the world to provide the newest treatments. He contributes to national treatment guidelines and practices evidence-based medicine. He is also the founder of the advocacy group The HealingNET Foundation, which focuses on increasing awareness and educating community health-care providers on the unique care NET patients require.
Sunday, November 6, 2022
